JOHN ROSTKOWSKI: Open Payments
NPI 1861424665 · CONCORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 6 payments from 4 companies in 2025. Trend: 2023 $367 · 2024 $765 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $234 |
| E.R. Squibb & Sons, L.L.C. | 2 | $207 |
| Otsuka America Pharmaceutical, Inc. | 1 | $117 |
| Neurocrine BioSciences, Inc. | 1 | $110 |
Products named: COBENFY, LYBALVI, REXULTI, ARISTADA, INGREZZA.
Industry payments across CA — which companies pay providers there.
